Circuit-Selective FAAH Inhibition Suppresses Experimental Absence Seizures.
Childhood absence epilepsy (CAE) arises from dysfunctional corticothalamic networks generating spike wave discharges (SWDs) and behavioral arrest. Despite av...
Cannabidiol Cortical Excitability Clinical Trial Results
Clinical Takeaway CBD alone does not directly reduce brain electrical activity or cause sedation in healthy individuals at doses up to 700 mg, suggesting its anti-seizure effects in clinical use arise primarily from interactions with other medications…
Cannabidiol Cortical Excitability Clinical Trial
Clinical Takeaway CBD did not directly reduce brain electrical excitability at doses up to 700 mg in healthy adults, suggesting its seizure-control benefits in approved conditions likely come from interactions with other anti-seizure medications rather…
Cannabidiol & Cortical Excitability: Clinical Trial Findings
Clinical Takeaway In this randomized controlled trial, neither a low (30 mg) nor a high (700 mg) single dose of CBD produced measurable changes in cortical excitability or sedation in healthy adults, suggesting CBD alone may not directly suppress…
Medical Cannabis and Epilepsy: The Evidence.
Epilepsy is a serious neurological condition that can affect individuals of all ages. Treatment is far from perfect, and roughly 30% of patients can experien...
Cannabinoid Clinical Trials: CBD & Cortical Excitability
Clinical Takeaway In this controlled trial of healthy adults, neither a low nor a high single dose of CBD directly altered cortical excitability compared to placebo, suggesting CBD may not have meaningful intrinsic anti-seizure properties on its own. The…
`Cannabidiol & Cortical Excitability: Clinical Trial Findings`
Clinical Takeaway In this randomized, double-blind, placebo-controlled crossover trial in healthy adults, neither a low nor a high single dose of CBD produced measurable changes in cortical excitability compared to placebo. This suggests that CBD’s…
Cannabinoids in Children: Medical Evidence Reviewed
Clinical Takeaway Cannabinoids have been studied across a wide range of pediatric medical conditions, with evidence drawn from interventional trials, observational data, and surveys. The current body of research reflects both potential therapeutic…
`Cannabidiol & Cortical Excitability: Clinical Trial Evidence`
Clinical Takeaway In a controlled crossover trial of healthy males, CBD at both low and high single doses failed to directly reduce cortical excitability compared to placebo, suggesting its anti-seizure effects may depend heavily on pharmacokinetic…
Endocannabinoid System Research: CBD & Cortical Excitability
Clinical Takeaway In a controlled crossover trial in healthy adults, CBD at both low and high doses showed no direct effect on cortical excitability compared to placebo, suggesting its anti-seizure benefit may depend more on its interaction with…